Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
about
Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic Inhibitors.Combined treatment with paclitaxel and suramin prevents the development of metastasis by inhibiting metastatic colonization of circulating tumor cells.
P2860
Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nontoxic suramin treatments en ...... ll cell lung xenograft tumors.
@en
type
label
Nontoxic suramin treatments en ...... ll cell lung xenograft tumors.
@en
prefLabel
Nontoxic suramin treatments en ...... ll cell lung xenograft tumors.
@en
P2093
P1476
Nontoxic suramin treatments en ...... ll cell lung xenograft tumors.
@en
P2093
Jessie L-S Au
Trini S-S Wientjes
P304
P356
10.1007/S11095-005-6038-1
P577
2005-07-22T00:00:00Z